NEW YORK Sept. 16 2016 PRNewswire &160;Immune Pharmaceuticals Inc. NASDAQ IMNP "Immune" or the "Company" a biopharmaceutical company focused on the development of targeted therapeutics for the treatment of inflammatory diseases and ...
↧